Lymphoma which is worse

Age is the most common type of risk factor between Hodgkin and non-Hodgkin lymphoma. The average age of someone who is diagnosed with non-Hodgkin lymphoma is 60, while most Hodgkin lymphomas occur in people ages 15 to 24, or over The type of lymphoma, its location and extent in the body determines your prognosis and treatment options.

Many people treated for both lymphomas receive some form of chemotherapy, radiation therapy, immunotherapy, targeted drug therapy, or a combination of them all.

Bone marrow or stem cell transplantation may also be done under special circumstances. Hodgkin lymphoma is considered one of the most treatable cancers, with more than 90 percent of patients surviving more than five years.

Most patients with Hodgkin lymphoma live long and healthy lives following successful treatment. Although slow growing forms of NHL are currently not curable, the prognosis is still good. In certain patients, treatment may not be necessary until there are signs of progression. Researchers continue to discover more about how lymphoma begins, as well as other treatment options.

Clinical trials are underway to find better ways of reducing symptoms and side effects of both lymphomas. Our patient services specialists can assist you with scheduling an appointment, questions about medical records, insurance, billing and more.

Patient Appointment Center Hours: 7 a. Monday - Friday; 8 a. Non-Hodgkin Lymphoma. Page Menu Hodgkin Lymphoma vs. In addition to the presence or lack of Reed-Sternberg cells, other differences between Hodgkin and non-Hodgkin lymphoma include that: Non-Hodgkin lymphoma is more common than Hodgkin lymphoma.

The majority of non-Hodgkin patients are over the age of 55 when first diagnosed, whereas the median age for diagnosis of Hodgkin lymphoma is Non-Hodgkin lymphoma may arise in lymph nodes anywhere in the body, whereas Hodgkin lymphoma typically begins in the upper body, such as the neck, chest or armpits.

What treatment options are available? Access Your Portal. Call: Call: Our patient services specialists can assist you with scheduling an appointment, questions about medical records, insurance, billing and more.

The primary diagnostic difference between Hodgkin and non-Hodgkin lymphomas may be determined during a biopsy, usually of an affected lymph node.

If a pathologist discovers Reed-Sternberg cells in the biopsy, the patient is diagnosed with Hodgkin lymphoma. Reed-Sternberg cells, named for the two scientists who first identified them under a microscope, are mutated B lymphocytes that are huge by cellular standards—up to five times larger than normal lymphocytes.

One common variety of these cells has at least two nuclei that give them the appearance of an owl's eyes. Another variety is called a popcorn cell because of its lobular shape. The different shapes of Reed-Sternberg cells may help pathologists determine the specific type of Hodgkin lymphoma. Hodgkin, a British pathologist, first chronicled some of the symptoms of the disease in a landmark article detailing the postmortem examinations of several patients with enlarged lymph nodes and spleens.

Thirty years later, another British physician, Dr. Samuel Wilks, learned of Hodgkin's work while conducting similar research. He named the condition Hodgkin's disease. The name of the disease has since lost the possessive and is called either Hodgkin disease or Hodgkin lymphoma.

In December , the U. And multiple clinical trials are underway to determine if immunotherapy drugs may also help treat non-Hodgkin lymphoma and other hematological malignancies, such as multiple myeloma. Make a difference in the fight against cancer by donating to cancer research.

Call us anytime. What's the difference?